Jutta Kroeber

Title: Jutta Kroeber: Innovator in Pharmaceutical Chemistry

Introduction

Jutta Kroeber is a distinguished inventor based in Bingen, Germany. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative processes for synthesizing important compounds. With a total of 5 patents to her name, Kroeber's work has had a substantial impact on the industry.

Latest Patents

Kroeber's latest patents focus on efficient processes for the manufacture of (E)-4-N,N-dialkylamino crotonic acid in HX salt form. This invention allows for the production of high-quality compounds where R and R denote C-alkyl groups, and X represents an acid anion, such as chloride or bromide. Additionally, she has developed a process for synthesizing EGFR tyrosine kinase inhibitors with heterocyclic structures, utilizing acid addition salts as intermediates. Another notable patent involves a multi-step process for preparing compounds that inhibit the binding of human intercellular adhesion molecules to leukointegrins, which are useful in treating inflammatory and immune cell-mediated diseases.

Career Highlights

Throughout her career, Kroeber has worked with prominent companies in the pharmaceutical sector, including Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharmaceuticals, Inc. Her expertise and innovative approaches have positioned her as a key player in the development of new therapeutic agents.

Collaborations

Kroeber has collaborated with notable colleagues such as Joerg Brandenburg and Rogelio Perez Frutos. These partnerships have further enhanced her research and development efforts in the pharmaceutical field.

Conclusion

Jutta Kroeber's contributions to pharmaceutical chemistry through her innovative patents and collaborations highlight her role as a leading inventor in the industry. Her work continues to influence the development of new treatments for various diseases.